Pharma and proactive, preventative healthcare: how to use the pharmacy channel
Across Europe, a shift towards greater prevention, earlier diagnosis and treatment is needed in order to contain the growing cost of healthcare.
But how can healthcare systems make this transition – and how do pharmaceutical companies play a role in this, while also growing their market?
A recent webinar hosted by pharmaphorum with sponsor PHOENIX group looks at how harnessing the data and expertise of pharmacies, and via greater engagement with patients, consumers and shoppers can meet this emerging need.
Key topics included:
- Industry: how can pharma switch from treating a disease to earlier health management? The role of preventative medicine, vaccines and early diagnosis explored
- The role of community pharmacies in prevention and health – increasing screening and diagnosis rates and facilitating appropriate medication
- How point of sale information in pharmacies can help generate a picture of patient groups and individuals. How loyalty card schemes support OTC and consumer spending patterns, which illuminate health needs, prescription patterns and purchasing behaviour.
Why watch the webinar?
The expert panel provides practical advice and real-life examples of how pharmaceutical companies can work with pharmacies to grow their market and better serve patient needs.
The live webinar took place on Wednesday 6 September at 14.00 BST/15.00 CEST/09.00 EDT. To view the webinar on-demand, please click here or on the button above/below.
John Munson, Head of Global Accounts, Mylan
John Munson is the Head of Global Accounts at Mylan, responsible for the account management of global customers and key European accounts. John joined Mylan in the UK in 2007 as Sales & Marketing Director and moved into the Country Manager role for the UK & IRE before taking up his current position. John has a 20 year history in pharmaceuticals with roles at Astra, Ivax and Ranbaxy and during his time at Mylan he has also held the position of Area Director for Northern and Western Europe. John studied Business, Finance and Marketing in Bournemouth and later gained an MBA from the same college. He is also a Member of the Chartered Institute of Marketing.
Nemanja Jankovic, Head of Commercial Partnerships Europe, PHOENIX group
Nemanja Jankovic heads the Commercial Partnerships at PHOENIX group and is responsible for strategic cooperation with the pharmaceutical industry on a European level. After working in the pharmaceutical industry for many years, the experienced market expert joined PHOENIX group four years ago.
Nina Felton, Head of Business Intelligence, PHOENIX group
Nina has extensive experience in the healthcare industry, having worked for companies such as Pfizer and Wyeth in marketing and sales roles, which involved the launching of new products. She also worked for over 12 years with IMS Health in their management consulting division. Nina started her career as a biochemist and has gained experience as the Managing Director of a primary market research company, in medical communications and is a qualified psychotherapist and executive coach. She joined the PHOENIX group two years ago and is responsible for developing their new initiatives in Business Intelligence, working across Europe.
Andrew McConaghie, Managing Editor, pharmaphorum (moderator)
Andrew is pharmaphorum’s managing editor, feature media. He writes on a range of topics covering pharmaceutical and biotech R&D, marketing and market access, and issues affecting patients and global healthcare systems, especially the UK’s NHS.